RETROLEAD
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RETROLEAD Trademark

Serial Number: 90278106 • Registration: 6551233

RETROLEAD is a trademark filed by Ruilidi (Shanghai) Biopharma Co., Ltd. on October 26, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Ruilidi (Shanghai) Biopharma Co., Ltd.

1288 Haike Road, Pudong New Area
Shanghai 200235 , CN

Entity Type: 16

Trademark Details

Filing Date

October 26, 2020

Registration Date

November 9, 2021

Published for Opposition

August 24, 2021

Goods & Services

Injectable pharmaceuticals preparations for the prevention and treatment of viral and infectious diseases, for the treatment of cancer; Injectable pharmaceuticals preparations for the prevention and treatment of bacteria-based diseases; Injectable pharmaceuticals preparations for the prevention and treatment of HIV/AIDS and hepatitis; Injectable pharmaceuticals preparations for the prevention and treatment of anaphylactic reactions; Medicinal preparations for the mouth to be applied in the form of capsules; Medicinal preparations for the mouth to be applied in the form of tablets; Biological preparations for the prevention and treatment of viral and infectious diseases, for the treatment of cancer; Biological preparations for the prevention and treatment of HIV/AIDS, hepatitis and liver diseases; Biological preparations for the prevention and treatment of respiratory system diseases; Pharmaceutical preparations for the prevention and treatment of HIV/AIDS; Pharmaceutical preparations for the prevention and treatment of liver diseases; Pharmaceutical preparations for the prevention and treatment of respiratory syncytial virus; Pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases, diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Medicines for antiviral purposes; Medicinal preparations for infective disorders; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the prevention and treatment of viral and infectious diseases; Dietetic foods adapted for medical use; Dietetic beverages adapted for medical use

Filing History

REGISTERED-PRINCIPAL REGISTER
Nov 9, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 24, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 24, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 4, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 19, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 12, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2021 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 12, 2021 AMPX
ASSIGNED TO LIE
Mar 8, 2021 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2020 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 4, 2020 PARI
NEW APPLICATION ENTERED
Oct 29, 2020 NWAP